6 stories tagged with #initiating, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Initiating"
Immunovant: Risk-Reward Set-Up Compelling, Initiating With A Speculative Buy
Initiate coverage of Immunovant (IMVT) with a BUY and $50 price target based on IMVT-1402’s best-in-class IgG reduction and ~$4B peak sales outlook. See more.…
Novo Nordisk: Initiating Buy, Calling The Bottom
Novo Nordisk's oral Wegovy is expanding the treated obesity market, not just cannibalizing injectables. Read why NVO stock is a Buy.…
Upstream Bio: The Reset Is The Opportunity, Initiating At Buy
Initiating a Buy rating on Upstream Bio, a small-cap biotech trading at an enterprise value under $200M. Click here to read my latest analysis of UPB stock.…
Personalis: Initiating Coverage Of Cancer Testing Biotech With A Buy Rating
Personalis, Inc. is rated Buy, driven by strong momentum in its NeXT Personal Dx MRD test and recent Medicare coverage expansions. Click for more on PSNL stock.…
VYMI: Initiating Coverage On Vanguard's Low-Cost International Dividend ETF
Explore Vanguard’s VYMI ETF: 4% yield, 0.07% fee, global diversification, and valuation vs VYM/IDV/SCHY.…
Carnival's Core Business Is Cruising - Initiating With A Buy
Carnival's fundamentals are robust, as demand is solid and net yield rises. Click here to see why CCL stock is a Buy.…